For research and education only · Not reviewed by a medical professional · Disclaimer

Peptide encyclopedia/ AHK-Cu
Illustration for AHK-Cu

THE PEPSRADAR ENCYCLOPEDIA

AHK-Cu

Hair-follicle and dermal papilla cell research

Research topics · Sources checked 2026-10-04

Read the studies ↓

AHK-Cu · KEY FACTS

Content updated · how dates work

Saved peptides

Compare: GHK-Cu vs AHK-Cu

What is AHK-Cu?

AHK-Cu is a copper complex of the tripeptide alanine-histidine-lysine. It is related to GHK-Cu but is a different molecule. Its featured evidence uses donated human hair follicles and cultured cells, not people using a product.

Biological role or research focus

Hair-follicle and dermal papilla cell research.

This was a single laboratory study using tissue and cells, not a clinical trial. It does not show hair regrowth in people, a useful product strength, or whether a topical product reaches the follicle.

Role reference: The effect of tripeptide-copper complex on human hair growth in vitro · 2007 ↗

Names you may encounter

Ala-His-Lys copper · L-alanyl-L-histidyl-L-lysine copper

Search terms can include brands, combinations, or historical names. They are not automatic product equivalents.

Class / identity
Copper(II) complex of the tripeptide alanine-histidine-lysine; related to, but distinct from, GHK-Cu
Research focus
Hair-follicle and dermal papilla cell research
Featured evidence
Human tissue (ex vivo) and cell study
Source check
October 4, 2026

Source: The effect of tripeptide-copper complex on human hair growth in vitro · 2007 ↗

Quick answers

Is AHK-Cu FDA approved?
No. No FDA-approved drug contains AHK-Cu. Source ↗
Is AHK-Cu safe?
AHK-Cu is a copper-peptide cosmetic ingredient studied only in donated hair follicles and cultured cells. No human safety studies, including skin irritation or allergy testing, have been published. Human safety data: none. The Risks & interactions section below lists what is known. Read the risks ↓
Is AHK-Cu banned in sport?
Very likely. The 2026 World Anti-Doping Agency (WADA) Prohibited List does not name it, but it appears to fall under a banned class (S0 Non-approved substances). Source ↗

What does the evidence show?

Evidence map

Every study featured on this page, grouped by what was actually tested. Human studies count most; animal and cell results often do not carry over to people.

1 Cell experiments
StudyTypePopulation / model
AHK-Cu in cultured human hair follicles and dermal papilla cells (2007)Human tissue (ex vivo) and cell studyHuman scalp hair follicles maintained in culture and cultured human dermal papilla cells.

Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.

Human tissue (ex vivo) and cell study · 2007

AHK-Cu in cultured human hair follicles and dermal papilla cells

What did this publication test, and what did it find?

Population / model
Human scalp hair follicles maintained in culture and cultured human dermal papilla cells.
Study design
Follicle-elongation measurements in organ culture, cell-proliferation assays, flow-cytometry apoptosis labeling, and protein markers (Bcl-2/Bax ratio, cleaved caspase-3 and PARP).
Main finding
Very low concentrations lengthened cultured follicles and increased dermal papilla cell growth. Protein markers pointed toward less apoptosis, although the drop in apoptotic cells itself was not statistically significant.
Limits & context
This was a single laboratory study using tissue and cells, not a clinical trial. It does not show hair regrowth in people, a useful product strength, or whether a topical product reaches the follicle.

Source: The effect of tripeptide-copper complex on human hair growth in vitro · 2007 ↗

Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.

Registered human trials

No study naming AHK-Cu as an intervention was found on ClinicalTrials.gov when we last checked (November 14, 2026). That means no registered human trial, not proof that none has ever been done elsewhere.

Search additional PubMed records ↗

Risks & interactions

AHK-Cu is a copper-peptide cosmetic ingredient studied only in donated hair follicles and cultured cells. No human safety studies, including skin irritation or allergy testing, have been published.

Human safety data: None

No published human safety studies were found. The featured study used donated hair follicles and cultured cells, so skin irritation, contact allergy and repeated use on the skin have not been studied in people.

Unassessed: no human safety data

It isn't approved, so there is no official list of who should avoid it, and no human safety studies have been published. No condition is tagged, but that does not make it safe for anyone. If a condition applies to you, talk to a doctor or pharmacist first.

Who should not use it

There is no official list, because it has never been approved as a medicine. That is not a sign it is safe for anyone: its risks have not been studied enough to know who is most at risk.

Summarized from published studies with AI assistance; not reviewed by a clinician. Not a complete list, and not medical advice: talk to a doctor or pharmacist about your own situation. Checked 2026-10-10. Sources: Tripeptide-copper complex and human hair growth in vitro (2007) ↗

Safety & what remains unknown

No human safety data were reported. Copper complexes can irritate skin, and repeated use, contact allergy and product formulation were not studied.

Source: The effect of tripeptide-copper complex on human hair growth in vitro · 2007 ↗

Evidence boundaries

This was a single laboratory study using tissue and cells, not a clinical trial. It does not show hair regrowth in people, a useful product strength, or whether a topical product reaches the follicle.

Source: The effect of tripeptide-copper complex on human hair growth in vitro · 2007 ↗

Regulatory status

U.S. FDA approval
Not approved
No FDA-approved drug containing this substance found in Drugs@FDA (openFDA data updated 2026-10-07). source
FDA compounding (503A bulk list)
Not on FDA’s compounding lists
Not found on FDA's 503A category 1, 2 or 3 lists (updated May 14, 2026) or the category 2 safety-risk page (updated April 22, 2026). source
World Anti-Doping Agency (2026)
Likely prohibited under a class rule · S0 Non-approved substances
Not named. S0 prohibits (at all times) any pharmacological substance not covered by another section and with no current approval by any government health authority for human therapeutic use; no such approval was found, so it is likely covered. It is mainly sold as a cosmetic ingredient; S0 is aimed at pharmacological use. source

Checked October 28, 2026. Rules change; follow the source links for the current status. Regulatory tracker.

This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.

Research context & identity

This profile covers laboratory hair-biology research. AHK-Cu appears in cosmetic-ingredient and research-chemical catalogs; neither listing shows that it regrows hair in people.

Source: The effect of tripeptide-copper complex on human hair growth in vitro · 2007 ↗

New editorial updates

Loading approved updates…

New source discoveries

Links appear automatically. Unreviewed discoveries are not verified medical findings.

Loading recent discoveries…

Explore the latest source feed →

Sources & supplier listings

Seller lab-report checks and prices are available to members. Sign up free

Biology & proposed mechanism

In the featured study, AHK-Cu increased the growth of hair follicles kept alive in culture and the multiplication of dermal papilla cells, which help control hair growth. The authors linked this to lower markers of programmed cell death. Follicle growth in a dish is a separate question from visible hair regrowth.

Source: The effect of tripeptide-copper complex on human hair growth in vitro · 2007 ↗

Questions worth asking

  • Is AHK-Cu the same as GHK-Cu?
  • What material, population, and route were actually studied?
  • This was a single laboratory study using tissue and cells, not a clinical trial. It does not show hair regrowth in people, a useful product strength, or whether a topical product reaches the follicle.
  • What adverse effects, uncertainty, and conflicts of interest does the original source report?

Frequently asked questions

Is AHK-Cu the same as GHK-Cu?

No. Both are copper complexes of short peptides, but the first amino acid differs (alanine versus glycine). Evidence for one does not automatically apply to the other.

Source: The effect of tripeptide-copper complex on human hair growth in vitro · 2007 ↗

Does the publication verify a supplier’s product?

No. The tested material and a commercial listing need separate identity and batch checks. A research-use disclaimer does not establish clinical suitability.

Source: The effect of tripeptide-copper complex on human hair growth in vitro · 2007 ↗

References & editorial record

Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation.

For research and education only. This page does not provide medical advice, diagnosis, or treatment. Research-only listings are not instructions for human use.

See something wrong on this page? Report a mistake · Corrections